Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
19-Aug-2026 | 553.35 | 565.5 | 544.4 | 555 | 12,832 | 13,46,08,977.1 | 1,31,547 |
20-Aug-2026 | 554.9 | 554.9 | 536.6 | 540.8 | 28,395 | 32,39,63,562.7 | 4,00,907 |
21-Aug-2026 | 544.85 | 560.95 | 539.05 | 556.95 | 12,910 | 26,05,34,431.6 | 3,18,158 |
24-Aug-2026 | 559.95 | 568.35 | 553.3 | 563.35 | 12,234 | 10,00,97,406.35 | 89,371 |
25-Aug-2026 | 566.95 | 569 | 563 | 566.7 | 8,089 | 8,52,48,585.7 | 93,054 |
26-Aug-2026 | 567 | 572.2 | 567 | 570.3 | 8,809 | 10,05,63,678.3 | 1,11,456 |
27-Aug-2026 | 573.15 | 579 | 568.05 | 576.9 | 13,284 | 17,10,31,936.35 | 1,94,092 |
28-Aug-2026 | 583.15 | 602 | 581.25 | 588.45 | 35,406 | 40,70,52,242.3 | 3,12,910 |
31-Aug-2026 | 589 | 591.95 | 568 | 582.35 | 18,705 | 24,13,78,470.35 | 1,48,838 |
01-Sep-2026 | 582 | 586 | 571.2 | 582.25 | 10,846 | 21,92,12,550.4 | 1,21,924 |
02-Sep-2026 | 584 | 593 | 579.05 | 582.2 | 10,010 | 7,90,23,156.35 | 55,059 |
03-Sep-2026 | 586 | 593 | 581 | 591.9 | 5,768 | 7,23,95,716.75 | 57,711 |
04-Sep-2026 | 593.4 | 593.4 | 584.9 | 588.7 | 14,831 | 14,09,20,630.75 | 1,26,367 |
07-Sep-2026 | 588.7 | 588.7 | 574.4 | 577.75 | 18,432 | 10,11,50,818.7 | 92,170 |
08-Sep-2026 | 578 | 588.75 | 577.3 | 582.2 | 7,051 | 16,39,13,202.9 | 2,35,405 |
09-Sep-2026 | 582.2 | 605 | 580.7 | 602.1 | 20,384 | 28,14,84,181.55 | 2,39,840 |
10-Sep-2026 | 605.15 | 607.5 | 590.6 | 595.65 | 23,741 | 17,43,04,586.85 | 1,49,082 |
11-Sep-2026 | 598.1 | 598.1 | 583 | 585.5 | 9,745 | 7,13,49,548.3 | 56,327 |
15-Sep-2026 | 586 | 591.5 | 569.85 | 572.5 | 9,442 | 6,82,21,553.55 | 63,515 |
16-Sep-2026 | 571 | 585 | 557.8 | 580.85 | 25,400 | 21,28,78,343.05 | 2,18,573 |
17-Sep-2026 | 580.55 | 590.1 | 577.55 | 586.3 | 12,087 | 7,56,58,546.65 | 60,666 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
